Position in NUVB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,336,385
+$1,458,200 QoQ
Shares Held
587,392
+34.2% QoQ
Ownership
0.167%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 242 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 0%
Shared 99%
None 1%
Common Shares in NUVB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. NUVB ranks #99 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in NUVB
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,336,385 | 587,392 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,878,185 | 437,806 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $10,618,878 | 1,185,143 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $1,840,918 | 497,546 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $767,156 | 393,414 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $647,277 | 367,772 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $878,830 | 330,388 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $739,769 | 323,044 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $949,606 | 325,208 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,172,129 | 322,014 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $352,013 | 233,122 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $297,191 | 221,785 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $392,048 | 217,805 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $364,230 | 219,417 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $94,606 | 49,275 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $110,084 | 49,145 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $159,656 | 49,277 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $324,535 | 61,699 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $532,482 | 62,645 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $332,193 | 33,420 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $189,439 | 20,348 | Shares | Defined | 2021-08-17 | |
| No filing history on record for this holder in this stock. | ||||||